Sertraline Hydrochloride
- Product NDC
- 69097-155
- 11-digit product format
- 690970155
- Labeler code
- 69097
- Product ID
- 69097-155_7dc4a6a5-6ada-4c47-9e9b-65124b4eebc4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sertraline Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA077162
- Marketing category
- ANDA
- Marketing start
- 2007-02-06
- Marketing end
- 0000-00-00
- Substance
- SERTRALINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69097-155-02 | 2020-02-06 | C162847 | 48780-1 | 9d75b9cf-dbad-f424-e053-dadaa90a57ce | ad8eb428-073d-4709-b38e-80c053d75e8a |
| 69097-155-05 | 2020-02-06 | C162847 | 48780-1 | 9d75b9cf-dbad-f424-e053-dadaa90a57ce | ad8eb428-073d-4709-b38e-80c053d75e8a |
| 69097-155-12 | 2020-02-06 | C162847 | 48780-1 | 9d75b9cf-dbad-f424-e053-dadaa90a57ce | ad8eb428-073d-4709-b38e-80c053d75e8a |
| 69097-155-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-dbad-f424-e053-dadaa90a57ce | ad8eb428-073d-4709-b38e-80c053d75e8a |
| 69097-155-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-dbad-f424-e053-dadaa90a57ce | ad8eb428-073d-4709-b38e-80c053d75e8a |
| 69097-155-12 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-dbad-f424-e053-dadaa90a57ce | ad8eb428-073d-4709-b38e-80c053d75e8a |